RNF26 antibody (N-Term)

Catalog No. ABIN6992190

Product Details anti-RNF26 Antibody

Target: RNF26 (Ring Finger Protein 26 (RNF26))

Binding Specificity: N-Term

Reactivity: Human, Rat

Host: Rabbit

Clonality: Polyclonal

Conjugate: This RNF26 antibody is un-conjugated

Application: ELISA, Western Blotting (WB)

Specificity: RNF26 Antibody is predicted to not cross-react with other CXCR familiy members.

Purification: RNF26 Antibody is affinity chromatography purified via peptide column.

Immunogen: RNF26 antibody was raised against a peptide corresponding to 14 amino acids near the amino terminus of human RNF26.

Isotype: IgG

Application Details

Application Notes: RNF26 antibody can be used for Western blot at 1 - 2 μ,g/mL.

Antibody validated: Western Blot in human and rat samples. All other applications and species not yet tested.

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: RNF26 Antibody is supplied in PBS containing 0.02 % sodium azide.

Preservative: Sodium azide

Precaution of Use: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Storage: -20 °C,4 °C

Storage Comment: RNF26 antibody can be stored at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

Target Details for RNF26

Target: RNF26 (Ring Finger Protein 26 (RNF26))

Alternative Name: RNF26 (RNF26 Products)

Synonyms: 8030450I18Rik antibody, ring finger protein 26 antibody, RNF26 antibody, Rnf26 antibody

Background: RNF26 Antibody: RNF26 was identified as a member of a novel C3HC5 ring finger subfamily (1). RNF26 is ubiquitously expressed in human tissues but has been found to be upregulated in several cancer cell lines including HL-60, HeLa S3, and SW480, as well as 50 % of primary gastric cancers. While the substrates of RNF26 ubiquitination have not yet been identified, the upregulation of RNF26 in several types of cancer suggest that it may serve as a target for therapeutic treatment (1).

Molecular Weight: Predicted: 48 kDa

Observed: 50 kDa

Gene ID: 79102

NCBI Accession: NP_114404

UniProt: Q9BY78